BaseLaunch
2026-09-01baselaunch.ch
Overview
What they do
Initiated in 2017 by Basel Area Business & Innovation, BaseLaunch serves as a critical bridge in the European biotech ecosystem. It provides early-stage therapeutic startups with up to CHF 500,000 in non-dilutive financing, lab infrastructure, and strategic guidance. What makes BaseLaunch distinctive is its "pharma-centric" model; it is backed by seven global pharmaceutical partners whose representatives sit on the selection board and help guide company creation. To date, its portfolio companies have collectively raised over $1 billion in follow-on financing.
baselaunch.ch
What they look for
BaseLaunch’s mission is to find breakthrough scientific innovation and de-risk it by collaborating with exceptional founders. They aim to build successful companies from scratch, getting them to a point where they can attract top-tier Series A investors, strategic pharma partners, and experienced management teams.
baselaunch.ch
Stage
Pre-seed, Seed, Ideation
baselaunch.ch
Sectors
Healthcare
baselaunch.ch
Based
Basel, CH
baselaunch.ch
Sources
2026-09-01baselaunch.chIncubators and accelerators are central to the global healthcare start-up ecosystem. We have…
2026-09-01baselaunch.chWe have a broad portfolio covering a wide range of therapeutic areas, and across modalities…
2026-09-01baselaunch.chBaseLaunch was initiated to help launch and grow the next generation of biotech companies. To…
2026-09-01baselaunch.chVirginia Ballotta, PhD [https://www.linkedin.com/in/virginia-ballotta-7822b929] Position…
Portfolio, cheque size and the rest
The 6 companies they have backed that we can see, the cheque they write, and whether they are deploying right now.
Start free, no cardFree accounts see every record.